A clinical study to compare the effects of Yavanyadi and Nishakathakadi tablets as an add-on medication in patients with Type 2 Diabetes mellitus.

Efficacy of Yavanyadi tablet as an add on medication in Type 2 Diabetes mellitus. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/069893

Enrollment

Registered

2024-07-04

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.participants of age group 25-75 years 2.HbA1c greater than 6.5% 3.FBS level from 126mg/dl -250mg/dl or PPBS level from 200mg/dl-400mg/dl 4.Under stable dose of an anti-diabetic therapy.

Exclusion criteria

Exclusion criteria: 1.HbA1c greater than 9.5% 2.Diagnosed cases of morbid cardiac & pulmonary HTN, metabolic complications like hyper-osmolar state 3. Pregnant or lactating women

Design outcomes

Primary

Measure	Time frame
Changes in blood parameters 1. FBS 2. PPBS 3. HbA1cTimepoint: Baseline,4weeks, 8weeks, 12weeks	—

Secondary

Measure	Time frame
1.For Standardization of the study drug physical parameters like Ash value, extractive value,TLC 2. Changes in Blood parameters of LFT, RFT 3.BMI Timepoint: Baseline and 90th day	—

Countries

India

Contacts

Public ContactDr Indulekha V C

Government Ayurveda College Thiruvananthapuram

shahulanchal@gmail.com9495311820

Outcome results